Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function.
Inflammatory bowel disease (IBD) is associated with Th1/Th2 cytokine dysregulation, leukocyte extravasation, and tissue edema, but the mechanisms for cytokine-mediated vascular dysfunction are not understood. To investigate how cytokines might control edema in IBD, we determined vascular permeability and IFN-gamma expression in two models of murine colitis: SCID mice reconstituted with CD45RB(high T-lymphocytes (CD45RB(high)/SCID mice), and interleukin-10 gene deficient (IL-10(-/-)) mice. We also investigated the in vitro effects of IFN-gamma and IL-10 on human endothelial solute barrier and junction protein expression. Vascular permeability in CD45RB(high)/SCID and IL-10(-/-) mice was quantified using tissue (131)I-IgG accumulation. The IFN-gamma message was quantified using the ribonuclease protection assay. Endothelial barrier integrity in vitro was measured by transmonolayer electrical resistance, and junctional proteins were examined by immunoblotting and fluorescence microscopy. Both CD45RB(high)/SCID and IL-10(-/-) mice exhibit enhanced colonic microvascular leakage and IFN-gamma message levels compared to their respective controls. In vitro, IFN-gamma also reduced endothelial barrier (monolayer electrical resistance, increased albumin permeability) and reduced tight junction (occludin) expression and staining. These effects were reversed by pretreatment of monolayers with IL-10. Therefore, in vivo IFN-gamma and IL-10 may modulate microvascular leakage in IBD partly by controlling the expression of intestinal endothelial tight junctional proteins.
Oshima
T
T
Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, USA.
Laroux
F S
FS
Coe
L L
LL
Morise
Z
Z
Kawachi
S
S
Bauer
P
P
Grisham
M B
MB
Specian
R D
RD
Carter
P
P
Jennings
S
S
Granger
D N
DN
Joh
T
T
Alexander
J S
JS
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects / Q000276:immunology*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D007371:Interferon-gamma / Q000276:immunology / Q000494:pharmacology; D016753:Interleukin-10 / Q000276:immunology / Q000494:pharmacology; D007422:Intestines / Q000098:blood supply / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D016513:Mice, SCID; D008833:Microcirculation
D016753:Interleukin-10; D007371:Interferon-gamma